Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wacher, Niels H
NCT05710783: Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.	Completed	2/3	4065	RoW	AVX-COVID/12, Recombinant NDV Vectored Vaccine for SARS-CoV-2, ChAdOx-1-S[recombinant], AstraZeneca COVID vaccine	Laboratorio Avi-Mex, S.A. de C.V., National Council of Science and Technology, Mexico, Instituto Nacional de Enfermedades Respiratorias	SARS-CoV-2 Infection	12/22	09/23